Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,864
Sort by:
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight
US$ 2,400.00
... Non Hodgkin Lymphoma therapeutics. “Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight” Report Highlight: Global Non Hodgkin Lymphoma Market Overview Mechanism of Non Hodgkin Lymphoma Therapeutics Global Non Hodgkin Lymphoma Pipeline by Type, Phase & Company Global Non Hodgkin Lymphoma Pipeline ...
November 2014
573 pages
Global Cancer Monoclonal Antibodies Market & Pipeline Insight
US$ 2,400.00
... Cancer Monoclonal Antibodies Pipeline by Phase, Indication, Company & Country Cancer Monoclonal Antibodies in Pipeline: 605 Majority Cancer Monoclonal Antibodies Preclinical Phase: 258 Marketed Cancer Monoclonal Antibodies: 34 Cancer Monoclonal Antibodies ...
October 2014
1400 pages
Global Cancer Kinase Inhibitors Market & Pipeline Insight
US$ 2,400.00
... Global Cancer Kinase Inhibitors Market & Pipeline Insight” Report Highlight: Classification & Mechanism of Kinase Inhibitors Cancer Kinase Inhibitors Therapy Market Overview Cancer Kinase Inhibitors Therapy Pipeline by Phase, Indication, Company & Country Marketed Cancer Kinase Inhibitors Therapy ...
October 2014
1500 pages
Global Breast Cancer Vaccine Clinical Trial Insight
US$ 1,200.00
... Breast Cancer Vaccine Clinical Trial Insight” Report Highlight: Global Breast Cancer Vaccine Market Overview Global Breast Cancer Vaccine Clinical Pipeline by Company, Phase & Country Mechanism of Breast Cancer Vaccine & Personalized Cancer Vaccines Detailed Clinical Insight on Breast Cancer Vaccine Pipeline ...
October 2014
134 pages
Global Cancer Vaccines Market & Pipeline Analysis
US$ 2,400.00
... Cancer Vaccines Delivery Cancer Vaccines: Mechanism & Innovations Global Cancer Vaccines Clinical Pipeline by Phase, Indication, Company & Country Global Cancer Vaccine Clinical Pipeline: 289 Vaccines Marketed Cancer Vaccines: 12 Vaccines Regulatory Framework for Cancer Vaccines Development & Marketing ...
September 2014
864 pages
Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014
US$ 2,000.00
... trials studies have demonstrated the fact that the potential of peptide based drugs to prevent and eradicate cancer is far effective than conventional ... therapy, both conventional and peptide based cancer therapeutics are used for the treatment. “Global Peptide Cancer Therapeutics Market & Pipeline Insight ...
August 2014
556 pages
Global Cancer Generics Market Outlook 2018
US$ 1,400.00
... growth. According to our latest research report “Global Cancer Generics Market Outlook 2018”, the global oncology market touched a mark of US$ 91 Billion in 2013 ... future incidences, regional analysis and patent expiration status of key cancer drugs. Analysis of key industry trends and drivers crucial to the ...
July 2014
100 pages
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies
US$ 3,900.00
... maintaining front line, product level access and education. In Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies, FirstWord ... marketed and four pipeline products Examination of physicians’ current usage of Medical Affairs teams services Key findings regarding the most and ...
July 2014
54 pages
2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
US$ 27,600.00
... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...
July 2014
1200 pages
2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
US$ 15,760.00
... is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the European Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, ...
July 2014
820 pages
2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
US$ 7,840.00
... be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... growing demand for malignancy assays and the rapid market expansion. US Market Overview Five-year test volume and sales projections ...
July 2014
620 pages
Cancer Immunotherapy Market & Clinical Pipeline Insight
US$ 3,000.00
... use. “Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights: Cancer Immunotherapy Market Overview Cancer Immunotherapy Market Dynamics Cancer Immunotherapy Pipeline: 1080 Drug in Clinical Pipeline Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country Cancer Vaccine Clinical ...
July 2014
1990 pages
Oncology Market Access Europe – Payer and Industry Perspectives
US$ 995.00
... experts from the UK, Germany, Italy, France and Spain, FirstWord’s Oncology Market Access Europe – Payer and Industry Perspectives lays out the current – and growing – challenges facing companies in getting drugs to the European market. Filled with compelling insight into the most pressing issues ranging ...
June 2014
75 pages
The US Anti Cancer Drug Market Outlook to 2018 - Demand of Oral Drugs to Drive Growth
US$ 900.00
... growth rate can be attributed to an increasing number of drugs being approved by the United States Food and Drug Association along with the increasing ... held a market share of ~% and recorded sales of USD ~ million. The US Anti Cancer Drug Market is expected to grow over the period at a CAGR of 29.4% with ...
June 2014
144 pages
Cancer Cytokines Therapy Pipeline Analysis
US$ 1,800.00
... are related to almost all the therapeutic protein drug development processes. The cytokine and growth factor related products include antibodies ... improve quality of life. “Cancer Cytokines Therapy Pipeline Analysis” Report Highlights: Cancer Cytokines Therapy Market Overview Marketed Drug Profiles & Patent ...
June 2014
231 pages
Cancer Cell Therapy Market & Pipeline Insight
US$ 2,400.00
... the spread of cancer. “Cancer Cell Therapy Market & Pipeline Insight” Report Highlights & Findings: Cancer Cell Therapy Market Overview Cancer Cell Therapy Market Dynamics Clinical Pipeline by Phase, country & Target Indications Cancer Cell Therapy Drugs in Pipeline: 82 Highest Number of Drugs in Preclinical ...
June 2014
195 pages
Deals in Oncology Personalized Medicine Industry – Worldwide Analysis
US$ 900.00
The Personalized Medicine in Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the world’s leading healthcare companies in oncology sector. All the deals have been tracked year wise. All the deals ...
May 2014
43 pages
New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape
US$ 27,600.00
... . DataPack (test volumes, sales forecasts, supplier shares) $21,100. New Frontiers in Cancer Diagnostics: Global Challenges, Emerging Technologies, Competitive Landscape is Venture ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer ...
April 2014
1200 pages
Physician Views – Are oncologists ready to embrace real-world data?
US$ 695.00
... have their own particular views on how this resource can be used to improve the treatment of patients in the future? Are they aware of the ... physician perceptive towards real-world data, FirstWord polled 192 oncologists based in the US and EU5. Specifically we asked them How aware they are ...
April 2014
Cancer Gene Therapy Market Analysis
US$ 1,800.00
... of Oncology Therapeutics in Gene Therapy Current Applications of Gene Therapy to Cancer Treatment Favorable Parameters for Cancer Gene Therapy Issued Involved with Application of Gene Therapy in Cancer Patients Regulatory Scenario for Gene Therapy Market Cancer Gene Therapy Drug Clinical ...
March 2014
300 pages
US Personalized Cancer Genome Sequencing Market Outlook 2018
US$ 1,200.00
... and the exponential decline in cost of whole genome sequencing. Our report entitled “US Personalized Cancer Genome Sequencing Market Outlook 2018” entails detailed ... in males and females. Further, we have provided potential states for whole genome sequencing to help market players gauge maximum opportunity for ...
February 2014
65 pages
Breast Cancer: New targeted therapies transform treatment - KOL Insight
US$ 7,495.00
... opinion This new KOL Insight report Breast Cancer –new targeted therapies transform treatment provides everyone interested in this dynamic cancer sector with a complete understanding of the targeted products ... and weaknesses of currently available targeted therapies for breast cancer Assess how prescribing trends will change with launch of new products Identify promising late-stage ...
February 2014
153 pages
French Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in French hospitals. Current instrumentation technologies and ...
January 2014
533 pages
German Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in German hospitals. Current instrumentation technologies and ...
January 2014
530 pages
Italian Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Italian hospitals. Current instrumentation technologies and ...
January 2014
525 pages
Japanese Hospital Tumor Marker Testing Market 2014
US$ 3,880.00
... 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Japanese hospitals. Current instrumentation technologies and ...
January 2014
537 pages
Spanish Hospital Tumor Marker Testing Market 2014
US$ 3,080.00
... 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the ... , oral, skin and others. Test volume and sales forecasts for 40 tumor markers performed in Spanish hospitals. Current instrumentation technologies and ...
January 2014
521 pages